Paxlovid May Offer Little Benefit for Vaccinated Older Adults

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on March 6, 2025.

By I. Edwards HealthDay Reporter

THURSDAY, March 6, 2025 -- The antiviral drug Paxlovid may not offer much protection against COVID-related hospitalizations or deaths for vaccinated older adults after all.

Research published recently in JAMA Network Open looked at data from more than 1.6 million adults ages 65 to 74 in Ontario, Canada, during 2022.

Most participants (nearly 88%) had received at least two doses of the COVID vaccine, and only certain high-risk groups or adults 70 and older were eligible for Paxlovid at the time.

The study found that Paxlovid did not significantly reduce the risk of hospitalization or death from COVID in this mostly vaccinated population.

“We were surprised and disappointed,” lead study author John Mafi, an associate professor of medicine at the David Geffen School of Medicine at UCLA, told The Washington Post.

“We concluded that it’s because it’s a highly vaccinated group with 88 percent fully vaccinated,” he added.

The findings could help older adults weigh the benefits and costs of taking Paxlovid.

“The cost is part of the calculus because it’s $1,650 per treatment course,” Mafi said. “I think that needs to be part of the conversation.”

A spokesperson for Pfizer, which makes Paxlovid, said the company stands by its effectiveness for patients at high risk for severe illness.

What's more, Paxlovid may still be helpful for certain high-risk groups, Mafi said.

“If you’re immunosuppressed, if you have cancer, chemotherapy, if you are frail, if you’re living in a nursing home, if you have end-stage kidney disease, if you’re an organ transplant recipient, those are very high-risk conditions,” he told The Post. “I would be more cautious in those groups.”

Paxlovid, a combination of nirmatrelvir and ritonavir, has been shown to reduce hospitalizations and deaths in unvaccinated, high-risk adults.

But prior research found it didn’t significantly shorten COVID symptoms in vaccinated adults.

At best, the drug lowered hospitalization risk by 1.3 percentage points in this new study.

“If you are vaccinated without additional risk factors, I wouldn’t prescribe Paxlovid, and I probably wouldn’t take it if I was a patient,” study co-author Dr. Peter Wu, associate professor of medicine at the University of Toronto, told The Post.

Sources

  • The Washington Post, March 5, 2025

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2025-03-07 06:00

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords